Wagner Wealth Management (South Carolina)’s Amneal Pharmaceuticals AMRX Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$1K	Buy	+29	New	+$610	﹤0.01%	586

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s AMRX Position: Q3 2018 in Review

Wagner Wealth Management (South Carolina) opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2018: 29 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #586 among its holdings.

167 funds tracked by Wall St. Rank hold AMRX as of Q3 2018.

Wagner Wealth Management (South Carolina) held 29 shares of Amneal Pharmaceuticals worth $1K as of Q3 2018.
Amneal Pharmaceuticals was a new Wagner Wealth Management (South Carolina) position in Q3 2018.
Amneal Pharmaceuticals made up ﹤0.01% of Wagner Wealth Management (South Carolina)'s portfolio in Q3 2018, its #586 holding.
167 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2018, filed 5 Nov 2018.